Novel biomarkers for risk stratification in pulmonary arterial hypertension
T Zelniker, L Uhlmann, S Spaich, J Friedrich, M Preusch, FJ Meyer, HA Katus, E Giannitsis · Pneumologie · 2016 · Heft 02
Bibliografische Angaben
Zusammenfassung
Background: Risk stratification in pulmonary arterial hypertension (PAH) is paramount to identify individuals at highest risk of death. So far, there are only limited parameters for prognostication in patients with PAH. Materials & Methods: Ninety-five patients with confirmed PAH were included in the present analysis and followed for a total of 4 years. Blood samples were analyzed for serum levels of NT-proBNP, hsTnT, proANP, GDF-15, sFlt-1, and PlGF. Results: Twenty-seven patients (28.4%) died during a follow-up of 4 years. Levels of all tested biomarkers except for PlGF were significantly elevated in non-survi…